Literature DB >> 17000666

Protein kinase C as a therapeutic target.

Beverly A Teicher1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17000666     DOI： 10.1158/1078-0432.CCR-06-0945

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  33 in total

1.  Conformationally constrained analogues of diacylglycerol. 29. Cells sort diacylglycerol-lactone chemical zip codes to produce diverse and selective biological activities.

Authors:  Dehui Duan; Dina M Sigano; James A Kelley; Christopher C Lai; Nancy E Lewin; Noemi Kedei; Megan L Peach; Jeewoo Lee; Thushara P Abeyweera; Susan A Rotenberg; Hee Kim; Young Ho Kim; Saïd El Kazzouli; Jae-Uk Chung; Howard A Young; Matthew R Young; Alyson Baker; Nancy H Colburn; Adriana Haimovitz-Friedman; Jean-Philip Truman; Damon A Parrish; Jeffrey R Deschamps; Nicholas A Perry; Robert J Surawski; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2008-08-13       Impact factor: 7.446

2.  Characterization of the differential roles of the twin C1a and C1b domains of protein kinase C-delta.

Authors:  Yongmei Pu; Susan H Garfield; Noemi Kedei; Peter M Blumberg
Journal:  J Biol Chem       Date:  2008-11-10       Impact factor: 5.157

3.  A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.

Authors:  C-H Chen; P Thai; K Yoneda; K B Adler; P-C Yang; R Wu
Journal:  Oncogene       Date:  2013-08-19       Impact factor: 9.867

4.  Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.

Authors:  Xue Wei Meng; Michael P Heldebrant; Karen S Flatten; David A Loegering; Haiming Dai; Paula A Schneider; Timothy S Gomez; Kevin L Peterson; Sergey A Trushin; Allan D Hess; B Douglas Smith; Judith E Karp; Daniel D Billadeau; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

5.  Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.

Authors:  Ching-Hsien Chen; Sarah Statt; Chun-Lung Chiu; Philip Thai; Muhammad Arif; Kenneth B Adler; Reen Wu
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

Review 6.  Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.

Authors:  M Meier; J Menne; H Haller
Journal:  Diabetologia       Date:  2009-02-24       Impact factor: 10.122

7.  IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Brian A Menegaz; Vandhana Ramamoorthy; Deeksha Vishwamitra; Ying Wang; Rebecca L Maywald; Adriana S Buford; Izabela Fokt; Stanislaw Skora; Jing Wang; Aung Naing; Alexander J Lazar; Eric M Rohren; Najat C Daw; Vivek Subbiah; Robert S Benjamin; Ravin Ratan; Waldemar Priebe; Antonios G Mikos; Hesham M Amin; Joseph A Ludwig
Journal:  J Natl Cancer Inst       Date:  2016-08-30       Impact factor: 13.506

8.  Self-assembly and lipid interactions of diacylglycerol lactone derivatives studied at the air/water interface.

Authors:  Liron Philosof-Mazor; Roman Volinsky; Maria J Comin; Nancy E Lewin; Noemi Kedei; Peter M Blumberg; Victor E Marquez; Raz Jelinek
Journal:  Langmuir       Date:  2008-09-13       Impact factor: 3.882

9.  Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma.

Authors:  Y Yang; Y Chen; M N Saha; J Chen; K Evans; L Qiu; D Reece; G A Chen; H Chang
Journal:  Leukemia       Date:  2014-09-02       Impact factor: 11.528

10.  Conformationally constrained analogues of diacylglycerol (DAG). 31. Modulation of the biological properties of diacylgycerol lactones (DAG-lactones) containing rigid-rod acyl groups separated from the core lactone by spacer units of different lengths.

Authors:  Maria J Comin; Gabriella Czifra; Noemi Kedei; Andrea Telek; Nancy E Lewin; Sofiya Kolusheva; Julia F Velasquez; Ryan Kobylarz; Raz Jelinek; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.